Eagle Pharmaceuticals (EGRX) Position Has Increased by Matarin Capital Management Llc; Concho Res Com (CXO) Shares Rose While Energy Opportunities Capital Management Has Lowered Holding by $1.21 Million

September 14, 2018 - By Ashley Bratcher

Concho Resources Inc. (NYSE:CXO) Logo

Matarin Capital Management Llc increased its stake in Eagle Pharmaceuticals Inc. (EGRX) by 407.79% based on its latest 2018Q2 regulatory filing with the SEC. Matarin Capital Management Llc bought 16,128 shares as the company’s stock declined 12.56% while stock markets rallied. The institutional investor held 20,083 shares of the health care company at the end of 2018Q2, valued at $1.52B, up from 3,955 at the end of the previous reported quarter. Matarin Capital Management Llc who had been investing in Eagle Pharmaceuticals Inc. for a number of months, seems to be bullish on the $1.00B market cap company. The stock decreased 0.15% or $0.1 during the last trading session, reaching $66.62. About 109,857 shares traded. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has risen 11.00% since September 14, 2017 and is uptrending. It has underperformed by 4.62% the S&P500. Some Historical EGRX News: 04/05/2018 – Eagle Pharma Closes Above 50-Day Moving Average: Technicals; 08/05/2018 – Eagle Pharma at Deutsche Bank Health Care Conference Tomorrow; 16/05/2018 – Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml; 16/04/2018 – EAGLE PHARMACEUTICALS’ VASOPRESSIN ANDA OK’D FOR FILING BY FDA; 07/05/2018 – Eagle Pharma Closes Above 200-Day Moving Average: Technicals; 16/04/2018 – EAGLE PHARMACEUTICALS’ VASOPRESSIN ANDA ACCEPTED FOR FILING BY; 10/04/2018 – Eagle Pharma at Deutsche Bank Health Care Conference May 9; 21/04/2018 – DJ Eagle Pharmaceuticals Inc, Inst Holders, 1Q 2018 (EGRX); 16/04/2018 – Eagle Pharmaceuticals’ Vasopressin ANDA Accepted For Filing By The FDA; 17/04/2018 – ENDO INTERNATIONAL – NOTICE LETTER ADVISING THAT EAGLE PHARMACEUTICALS SUBMITTED ANDA TO FDA SEEKING APPROVAL TO MARKET GENERIC VERSION OF VASOSTRICT

Energy Opportunities Capital Management Llc decreased its stake in Concho Res Inc Com (CXO) by 28.64% based on its latest 2018Q2 regulatory filing with the SEC. Energy Opportunities Capital Management Llc sold 8,800 shares as the company’s stock rose 6.54% with the market. The institutional investor held 21,925 shares of the oil & gas production company at the end of 2018Q2, valued at $3.03M, down from 30,725 at the end of the previous reported quarter. Energy Opportunities Capital Management Llc who had been investing in Concho Res Inc Com for a number of months, seems to be less bullish one the $28.08B market cap company. The stock decreased 0.61% or $0.87 during the last trading session, reaching $140.96. About 1.39 million shares traded. Concho Resources Inc. (NYSE:CXO) has risen 21.27% since September 14, 2017 and is uptrending. It has outperformed by 5.65% the S&P500. Some Historical CXO News: 21/04/2018 – DJ Concho Resources Inc, Inst Holders, 1Q 2018 (CXO); 28/03/2018 – Concho Resources Will Continue to Be Headquartered in Midland, Texas; 28/03/2018 – Len Vermillion: #BREAKING: Concho acquiring RSP Permian in $9.5 billion merger; 29/03/2018 – CONCHO RESOURCES INC CXO.N : KLR GROUP RAISES TARGET PRICE BY $5 TO $164; RATING HOLD; 26/03/2018 – CONCHO RESOURCES INC CXO.N CEO SAYS EXPECTS MANY MORE ‘SMALL IMPROVEMENTS’ IN WELL EFFICIENCIES IN NEXT 2-3 YEARS; 28/03/2018 – CONCHO RESOURCES INC – AS PART OF DEAL, CO EXPECTS TO REALIZE OVER $60 MLN IN ANNUAL CORPORATE LEVEL SAVINGS; 01/05/2018 – Concho Resources 1Q Rev $947M; 28/03/2018 – RSP PERMIAN SAYS CONCHO CHAIRMAN & CEO TIM LEACH WILL CONTINUE TO LEAD COMBINED CO – SEC FILING; 25/05/2018 – Concho Closes Below 200-Day Moving Average: Technicals; 28/03/2018 – CONCHO TO BUY RSP PERMIAN IN DEAL VALUED AT $9.5B WITH DEBT

Investors sentiment increased to 1.1 in Q2 2018. Its up 0.12, from 0.98 in 2018Q1. It increased, as 48 investors sold CXO shares while 144 reduced holdings. 65 funds opened positions while 146 raised stakes. 153.79 million shares or 7.26% more from 143.38 million shares in 2018Q1 were reported. Retirement Systems Of Alabama invested in 0.13% or 189,015 shares. Federated Pa accumulated 2,254 shares. Janney Montgomery Scott Lc reported 2,382 shares or 0% of all its holdings. Csat Investment Advisory LP holds 70 shares or 0.01% of its portfolio. Envestnet Asset Management has invested 0% of its portfolio in Concho Resources Inc. (NYSE:CXO). Adams Natural Fund Inc owns 70,100 shares. Tributary Capital Mgmt Ltd Liability Company holds 0.11% in Concho Resources Inc. (NYSE:CXO) or 13,100 shares. Pitcairn has invested 0.03% in Concho Resources Inc. (NYSE:CXO). Vanguard Group holds 0.09% of its portfolio in Concho Resources Inc. (NYSE:CXO) for 15.57 million shares. Fjarde Ap owns 44,720 shares. Northern accumulated 1.90M shares or 0.07% of the stock. Usa Portformulas Corp holds 2,619 shares. Cap Intll Inc Ca owns 2,400 shares for 0.05% of their portfolio. Architects has invested 0.01% in Concho Resources Inc. (NYSE:CXO). 45,930 are owned by Proshare Advsrs Ltd Co.

Analysts await Concho Resources Inc. (NYSE:CXO) to report earnings on October, 30. They expect $1.11 earnings per share, up 146.67% or $0.66 from last year’s $0.45 per share. CXO’s profit will be $221.08M for 31.75 P/E if the $1.11 EPS becomes a reality. After $1.24 actual earnings per share reported by Concho Resources Inc. for the previous quarter, Wall Street now forecasts -10.48% negative EPS growth.

Energy Opportunities Capital Management Llc, which manages about $585.78M and $164.02M US Long portfolio, upped its stake in Cheniere Energy Inc Com New (NYSEMKT:LNG) by 5,375 shares to 26,310 shares, valued at $1.72 million in 2018Q2, according to the filing. It also increased its holding in Dril (NYSE:DRQ) by 13,525 shares in the quarter, for a total of 72,273 shares, and has risen its stake in Valero Energy Corp New Com (NYSE:VLO).

Among 33 analysts covering Concho Resources Inc. (NYSE:CXO), 20 have Buy rating, 0 Sell and 13 Hold. Therefore 61% are positive. Concho Resources Inc. had 135 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, August 24. The rating was downgraded by Cowen & Co to “Market Perform” on Monday, April 18. The rating was maintained by Morgan Stanley on Wednesday, October 18 with “Overweight”. The firm has “Neutral” rating by Suntrust Robinson given on Tuesday, October 6. The rating was maintained by Citigroup on Friday, July 21 with “Buy”. On Monday, September 18 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The firm earned “Buy” rating on Thursday, September 3 by SunTrust. Cowen & Co initiated the shares of CXO in report on Wednesday, December 9 with “Market Perform” rating. The rating was maintained by Cowen & Co with “Hold” on Thursday, October 19. The stock has “Buy” rating by Goldman Sachs on Wednesday, July 18.

Since July 19, 2018, it had 0 buys, and 2 selling transactions for $1.82 million activity. 11,000 Concho Resources Inc. (NYSE:CXO) shares with value of $1.47 million were sold by Nelson Erick.

Matarin Capital Management Llc, which manages about $198.00M and $1382.93 billion US Long portfolio, decreased its stake in Celestica Inc. (NYSE:CLS) by 25,528 shares to 204,848 shares, valued at $2.43B in 2018Q2, according to the filing. It also reduced its holding in Hilltop Holdings Inc. (NYSE:HTH) by 60,117 shares in the quarter, leaving it with 54,342 shares, and cut its stake in Powell Industries Inc. (NASDAQ:POWL).

Among 5 analysts covering Eagle Pharma (NASDAQ:EGRX), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Eagle Pharma had 28 analyst reports since July 29, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of EGRX in report on Wednesday, August 9 with “Buy” rating. Mizuho initiated Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) rating on Wednesday, December 9. Mizuho has “Buy” rating and $112 target. Mizuho maintained the shares of EGRX in report on Monday, May 7 with “Sell” rating. The firm earned “Outperform” rating on Tuesday, May 10 by RBC Capital Markets. The firm has “Outperform” rating by William Blair given on Wednesday, November 2. Mizuho downgraded Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) on Wednesday, November 16 to “Neutral” rating. The firm earned “Neutral” rating on Monday, June 20 by Mizuho. The stock has “Buy” rating by Mizuho on Wednesday, October 26. RBC Capital Markets maintained Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) rating on Friday, September 1. RBC Capital Markets has “Buy” rating and $81.0 target. RBC Capital Markets maintained Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) on Friday, July 14 with “Buy” rating.

Concho Resources Inc. (NYSE:CXO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts